Thymulin reverses inflammatory hyperalgesia and modulates the increased concentration of proinflammatory cytokines induced by i.c.v. endotoxin injection

Neuroscience

Volumn 121, Issue 4, 2003, Pages 865-873

  Safieh Garabedian, B ^a   Ochoa Chaar, C I ^a   Poole, S ^b   Massaad, C A ^a   Atweh, S F ^a   Jabbur, S J ^a   Saade N E ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Brain; Cytokines; Endotoxin; Hyperalgesia; Neuroinflammation

Indexed keywords

CYTOKINE; ENDOTOXIN; SODIUM CHLORIDE; THYMULIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CONSCIOUSNESS; CONTROLLED STUDY; HYPERALGESIA; INJECTION; MALE; NOCICEPTION; NONHUMAN; PAIN ASSESSMENT; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; STATISTICAL SIGNIFICANCE; UPREGULATION;

EID: 0142247469     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(03)00500-1     Document Type: Article

References (42)

1. Balasingam V., Tejada-Berges T., Wright E., Bouckova R., Young V.W. Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines. J Neurosci. 14:1994;846-856.
2. Boivie, J (1994) Central pain. In: Textbook of pain (Wall PD, Melzack R, eds), pp 871-902. London: Churchill Livingstone.
3. Dantzer R. Cytokine-induced sickness behavior where do we stand . Brain Behav Immun. 15:2001;7-24.
4. Dantzer R., Bluthé R.M., Layé S., Bret-Dibat J.L., Parnet P., Kelley K.W. Cytokines and sickness behavior. Ann NY Acad Sci. 840:1998;586-590.
5. De Simoni M.G., Del Bo R., De Luigi A., Simard S., Forloni G. Central endotoxin induces different patterns of interleukin (IL)-1β and IL-6 messenger ribonucleic acid expression and IL-6 secretion in the brain and periphery. Endocrinology. 136:1995;897-902.
6. Dinarello C.A., Gelfand J.A., Wolff S.M. Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. JAMA. 269:1993;1829-1835.
7. Faggioni R., Fantuzzi G., Villa P., Buurman W., Van Tits L.J.H., Ghezzi P. Independent down-regulation of central and peripheral tumor necrosis factor production as a result of lipopolysaccharide tolerance in mice. Infect Immun. 63:1995;1473-1477.
8. Finck B.N., Dantzer R., Kelley K.W., Woods J.A., Johnson R.W. Central lipopolysaccharide elevates plasma IL-6 concentration by an alpha- adrenoreceptor-mediated mechanisms. Am J Physiol. 272:1997;R1880-R1887.
9. Hargreaves K.M., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1998;77-88.
10. Hori T., Oka T., Hosoi M., Abe M., Oka K. Biphasic modulation of pain by hypothalamic cytokines. Saadé N.E. Pain and neuroscience interactions. 2000;171-189 Kluwer Academic/Plenum Publishers, New York.
11. Huber T.S., Gaines G.C., Welborn M.B. 3rd, Rosenburg J.J., Seeger J.M., Moldawer L.L. Anticytokine therapies for acute inflammation and the systemic inflammatory response syndrome IL-10 and ischemia/reperfusion injury as new paradigm . Shock. 13:2000;425-434.
12. Juedes A.E., Hjelmstrom P., Bergman C.M., Neild A.L., Ruddle N.H. Kinetics and cellular origin of cytokines in the central nervous system insight into mechanisms of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis . J Immunol. 164:2000;419-426.
13. Kanaan S.A., Saadé N.E., Haddad J.J., Abdelnoor A.M., Atweh S.F., Jabbur S.J., Safieh-Garabedian B. Endotoxin-induced local inflammation and hyperalgesia in rats and mice a new model for inflammatory pain . Pain. 66:1996;370-373.
14. Kato S., Nakamura H. Suppression of acute experimental allergic encephalomyelitis by synthetic serum thymic factor: clinical, histopathological, and immunohistochemical studies. Acta Neuropathol. 75:1988;337-344.
15. Konsman J.P., Parnet P., Dantzer R. Cytokine-induced sickness behavior mechanisms and implications . Trends Neurosci. 25:2002;154-159.
16. Laye S., Parnet P., Gouijon E., Dantzer R. Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. Brain Res Mol Brain Res. 27:1994;157-162.
17. Lemke R., Hartlage-Rubsamer M., Schleibs R. Differential injury-dependent glial expression of interleukin-1 alpha, beta, and interleukin-6 in rat brain. Glia. 27:1999;75-87.
18. Liu J., Marino M.W., Wong G., Grail D., Dunn A., Bettadapura J., Slavin A.J., Old L., Bernard C.C. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat Med. 4:1998;78-83.
19. Nadeau S., Rivest S. Role of microglial-derived tumor necrosis factor in mediating CD14 transcription and nuclear κB activity in the brain during endotoxemia. J Neurosci. 20:2000;3456-3468.
20. Oka T., Aou S., Hori T. Intracerebroventricular injection of interleukin-1β induces hyperalgesia in rats. Brain Res. 624:1993;61-68.
21. Oka T., Oka K., Hosoi M., Hori T. Intracerebroventricular injection of interleukin-6 induces thermal hyperalgesia in rats. Brain Res. 692:1995;123-128.
22. Poole S., Cunha F.Q., Ferreira S.H. Bradykinin, cytokines and inflammatory hyperalgesia. Saadé N.E., Apkarian A.V., Jabbur S.J. Pain and neuroimmune interactions. 2000;31-45 Kluwer Academic/Plenum Publishers, New York.
23. Quan N., Whiteside M., Herkenham M. Time course and localization patterns of interleukin-1β messenger RNA expression in brain and pituitary after peripheral administration of lipopolysaccharide. Neuroscience. 83:1998;281-293.
24. Rothwell N.J., Luheshi G.N. Interleukin 1 in the brain biology, pathology and therapeutic target . Trends Neurosci. 23:2000;618-625.
25. Ruddle N.H., Bergman C.M., McGrath K.M., Lingenheld E.G., Grunnet M.L., Padula S.J., Clark R.B. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J Exp Med. 172:1990;1193-1200.
26. Saadé N.E., Major S.C., Jabbur S.J., Atweh S.F., Kanaan S.A. Involvement of capsaicin sensitive primary afferents in thymulin-induced hyperalgesia. J Neuroimmunol. 91:1998;171-179.
27. Safieh-Garabedian B., Kendall M.D., Khamashta M.A., Hughes G.R.V. Thymulin and its role in immunomodulation. J Autoimmun. 5:1992;547-555.
28. Safieh-Garabedian B., Poole S., Allchorne A., Winter J., Woolf C.J. Contribution of interleukin-1β to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br J Pharmacol. 115:1995;1265-1275.
29. 2 in endotoxin induced localized inflammatory hyperalgesia. Br J Pharmacol. 121:1997;1619-1626.
30. Safieh-Garabedian B., Jalakhian R.H., Jabbur S.J., Saadé N.E., Kanaan S.A. Thymulin in high doses reduces endotoxin-induced hyperalgesia by reducing interleukin-1β and nerve growth factor levels in the hind paw of rats. Apkarian A.V., Ayrapetian S. Pain mechanisms and management. 1998;131-138 IOS Press, Amsterdam.
31. Safieh-Garabedian B., Kanaan S.A., Jabbur S.J., Saadé N.E. Cytokine mediated or direct effects of thymulin on the nervous system. Neuroimmunomodulation. 6:1999;39-44.
32. 2 in thymulin induced hyperalgesia. Neuropharmacology. 39:2000;1653-1661.
33. Sanna P.P., Weiss F., Samson M.E., Bloom F.E., Pich E.M. Rapid induction of tumor necrosis factor α in the cerebrospinal fluid after intracerebroventricular injection of lipopolysaccharide revealed by a sensitive capture immuno-PCR assay. Proc Natl Acad Sci USA. 92:1995;272-275.
34. Selmaj K.W., Raine C.C.S. Tumour necrosis factor mediates myelin and oligodendrocytes damage in vitro. Ann Neurol. 23:1988;339-346.
35. Schoneboom B.A., Catlin K.M., Marty A.M., Greider F.B. Inflammation is a component of neurodegeneration in response to Venezuelan equine encephalitis virus infection in mice. J Neuroimmunol. 109:2000;132-146.
36. Spranger M., Fontana A. Activation of microglia a dangerous interlude in immune function in the brain . Neuroscientist. 2:1996;293-299.
37. Tarkowski E., Blennow K., Wallin A., Tarkowski A. Intracerebral production of tumor necrosis factor-α, a local neuroprotective agent, in Alzheimer disease and vascular dementia. J Clin Immunol. 19:1999;223-230.
38. Tasker R.R., de Carvalho G., Dostrovsky J.O. The history of central pain syndromes, with observations concerning pathophysiology and treatment. Casey K.L. Pain and central nervous system disease: the central pain syndromes. 1991;31-58 Raven Press, New York.
39. Turrin N.P., Gayle D.A., Ilyin S.E., Flynn M.C., Langhans W., Schwartz G.J., Plata-Salaman C.R. Pro-inflammatory and anti-inflammatory cytokine mRNA induction in the periphery and brain following intraperitoneal administration of bacterial lipopolysaccharide. Brain Res Bull. 54:2001;443-453.
40. Vernet der Garabedian B., Lemaigre-Dubreuil Y., Mariani J. Central origin of IL-1β produced during peripheral inflammation role of meninges . Mol Brain Res. 75:2000;259-263.
41. Walker K., Dray A., Perkins M. Hyperalgesia in rats following intracerebroventricular administration of endotoxin effect of bradykinin B1 and B2 receptor antagonist treatment . Pain. 65:1996;211-219.
42. Woiciechowsky C., Schöning B., Daberkow N., Asche K., Stoltenburg G., Lanksch W.R., Volk H.-D. Brain-IL-1β induces local inflammation but systemic anti-inflammatory response through stimulation of both hypothalamus-pituitary-adrenal axis and sympathetic nervous system. Brain Res. 816:1999;563-571.